Journal Article

Hyperinflammatory syndrome in a paediatric patient with a recent diagnosis of HIV/AIDS infection: hemophagocytic lymphohistiocytosis or immune reconstitution syndrome?

Palma, Paolo, Leone, Fabrizio, Casamento Tumeo, Chiara, Adorisio, Rachele, Zangari, Paola, Bernardi, Stefania, Bracaglia, Claudia, Papoff, Paola, Ajassa, Camilla, Cotugno, Nicola, De Benedetti, Fabrizio, Palomba, Patrizia

2023

Overview

Introduction Haemophagocytic lymphohistiocytosis is a rare and life-threatening condition caused by uncontrolled immune activation leading to excessive inflammation and tissue destruction. It could either be due to a primary genetic defect or be triggered by secondary causes such as infections, autoimmune diseases, rheumatological diseases or post-transplant immunosuppression. We here report the case of a 4-year-old child with a recent AIDS diagnosis who developed a severe systemic inflammation. Case report We here report the case of a 4-year-old child with a recent AIDS diagnosis who was admitted to the ER with acute respiratory failure due to Pneumocystis jiroveci infection and Aspergillosis; the following microbiological assessment also showed a CMV, HSV, EBV and HHV-7 coinfection. On the 51st day after she’d started antiretroviral therapy, 39th after she’d followed a course of Bactrim and Caspofungin for PJI and Ambisome for pulmonary Aspergillosis, she started presenting fever, unresponsive to broad-spectrum antibiotic therapy. She also presented worsening of her clinical conditions, with evidence at the laboratory assessments of progressive raise in inflammatory indexes, coagulopathy, trilinear cytopenia and hyperferritinemia. To perform the differential diagnosis between IRIS and HLH, HLA-DR on T cells was studied, turning out negative for IRIS. Therefore, in the suspicion of HLH, a bone marrow aspirate and biopsy were performed with evidence of trilinear cytopenia, prevalence of T-cells and macrophages with signs of phagocytosis. She was started on high-dose steroids and Anakinra for a total of 29 days, resulting in prompt apyrexia and progressive improvement of her clinical conditions and laboratory results. Conclusion To the best of our knowledge there is poor literature available about the differential diagnosis of HLH and IRIS, therefore medical management in the concurrence of these two conditions needs to be further investigated, especially in a setting where immunological testing is not quickly available. The clinical differences between these pathologies are blurred and the bone marrow biopsy within marker for IRIS helped us to distinguish these two entities.

• Publisher: BioMed Central,BioMed Central Ltd,Springer Nature B.V,BMC
• Subject: Acquired immune deficiency syndrome / AIDS / Antibiotics / Antifungal agents / Antigens / Antiretroviral agents / Antiretroviral drugs / Antiretroviral therapy / Antiviral agents / Aspergillosis / Autoimmune diseases / Biopsy / Bone marrow / Care and treatment / Case Report / Caspofungin / Comorbidity / Cytokines / Diagnosis / Differential diagnosis / Dosage and administration / Epstein-Barr virus / Fever / Histiocytosis / HIV / HIV infection in children / HLH / Human immunodeficiency virus / Immune reconstitution / Immunology / Immunosuppression / Immunotherapy / Infection / Infections / Infectious Diseases / Inflammation / Interleukin 1 receptor antagonist / Internal Medicine / IRIS / Laboratories / Lymphatic diseases / Lymphocytes / Lymphocytes T / Lymphocytosis / Macrophages / Medical Microbiology / Medicine / Medicine & Public Health / Mortality / Multisystem inflammatory syndrome in children / Parasitology / Patient outcomes / Pediatric / Phagocytosis / Prevention / Risk factors / Severe acute respiratory syndrome coronavirus 2 / Steroid hormones / Tropical Medicine / Viral infections